NCT01859819View on ClinicalTrials.gov

Treatment for Advanced B-Cell Lymphoma

PHASE2CompletedINTERVENTIONAL
Enrollment

45

Participants

Timeline

Start Date

January 31, 2013

Primary Completion Date

June 30, 2020

Study Completion Date

June 30, 2021

Conditions
Diffuse Large Cell LymphomaBurkitt's LymphomaHigh Grade B-cell Lymphoma
Interventions
DRUG

Rituximab

DRUG

IT Cytarabine

Trial Locations (5)

10595

New York Medical College, Valhalla

14263

Roswell Park Cancer Institute, Buffalo

28204

Levine Children's Hospital, Charlotte

73104

University of Oklahoma Health Sciences Center, Oklahoma City

84112

University of Utah, Salt Lake City

Sponsors
All Listed Sponsors
lead

New York Medical College

OTHER

NCT01859819 - Treatment for Advanced B-Cell Lymphoma | Biotech Hunter | Biotech Hunter